Patient Safety Organizations: Voluntary Relinquishment for the Emergency Medical Error Reduction Group PSO, 24190-24191 [2023-08247]
Download as PDF
<![CDATA[
24190
Federal Register / Vol. 88, No. 75 / Wednesday, April 19, 2023 / Notices
Dated: April 14, 2023.
JoAnne O’Bryant,
Program Analyst.
Eagle Sub, LLC, with First Mid
Bancshares, Inc., as the surviving entity.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–08253 Filed 4–18–23; 8:45 am]
BILLING CODE 6730–02–P
[FR Doc. 2023–08261 Filed 4–18–23; 8:45 am]
BILLING CODE P
FEDERAL RESERVE SYSTEM
lotter on DSK11XQN23PROD with NOTICES1
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than May 19, 2023.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. First Mid Bancshares, Inc., through
its subsidiary Eagle Sub, LLC, both of
Mattoon, Illinois, to acquire Blackhawk
Bancorp, Inc., and thereby indirectly
acquire Blackhawk Bank, both of Beloit,
Wisconsin. Additionally, Eagle Sub,
LLC, to become a bank holding
company upon the merger (the ‘‘interim
holding company merger’’) of
Blackhawk Bancorp, Inc., with and into
Eagle Sub, LLC. Finally, following the
interim holding company merger, First
Mid Bancshares, Inc., to merge with
VerDate Sep<11>2014
16:37 Apr 18, 2023
Jkt 259001
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy. Agenda
items for this meeting are subject to
change as priorities dictate.
Dated: April 13, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023–08250 Filed 4–18–23; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4160–90–P
Agency for Healthcare Research and
Quality
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Meeting
Agency for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of AHRQ subcommittee
meeting.
AGENCY:
The subcommittee listed
below is a part of AHRQ’s Health
Services Research Initial Review Group
(IRG) Committee. Grant applications are
to be reviewed and discussed at this
meeting. The subcommittee meeting
will be closed to the public.
DATES: See below for date of meeting:
1. Healthcare Safety and Quality
Improvement Research (HSQR)
Date: June 14–15, 2023
ADDRESSES: Agency for Healthcare
Research and Quality (Virtual Review),
5600 Fishers Lane, Rockville, Maryland
20857.
FOR FURTHER INFORMATION CONTACT: (To
obtain a roster of members, agenda or
minutes of the non-confidential portions
of the meeting.) Jenny Griffith,
Committee Management Officer, Office
of Extramural Research Education and
Priority Populations, Agency for
Healthcare Research and Quality
(AHRQ), 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 427–
1557.
SUPPLEMENTARY INFORMATION: In
accordance with section 10 (a)(2) of the
Federal Advisory Committee Act (5
U.S.C. app. 2), AHRQ announces
meetings of the above-listed scientific
peer review group, which is a
subcommittee of AHRQ’s Health
Services Research Initial Review Group
Committee. The subcommittee meeting
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2 section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Patient Safety Organizations:
Voluntary Relinquishment for the
Emergency Medical Error Reduction
Group PSO
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
The Patient Safety and
Quality Improvement Final Rule
(Patient Safety Rule) authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a patient safety organization (PSO) an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient
Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason, or when a PSO’s
listing expires. AHRQ accepted a
notification of proposed voluntary
relinquishment from the Emergency
Medical Error Reduction Group PSO,
PSO number P0235, of its status as a
PSO, and has delisted the PSO
accordingly.
SUMMARY:
The delisting was effective at
12:00 Midnight ET (2400) on March 29,
2023.
ADDRESSES: The directories for both
listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. Both
directories can be accessed
electronically at the following HHS
website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
DATES:
E:\FR\FM\19APN1.SGM
19APN1
Federal Register / Vol. 88, No. 75 / Wednesday, April 19, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
Background
The Patient Safety Act, 42 U.S.C.
299b-21 to 299b-26, and the related
Patient Safety Rule, 42 CFR part 3,
published in the Federal Register on
November 21, 2008 (73 FR 70732–
70814), establish a framework by which
individuals and entities that meet the
definition of provider in the Patient
Safety Rule may voluntarily report
information to PSOs listed by AHRQ, on
a privileged and confidential basis, for
the aggregation and analysis of patient
safety work product.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
PSOs.
AHRQ has accepted a notification of
proposed voluntary relinquishment
from the Emergency Medical Error
Reduction Group PSO to voluntarily
relinquish its status as a PSO.
Accordingly, the Emergency Medical
Error Reduction Group PSO, P0235, was
delisted effective at 12:00 Midnight ET
(2400) on March 29, 2023.
More information on PSOs can be
obtained through AHRQ’s PSO website
at https://www.pso.ahrq.gov.
Lisa
Granger, Office of Policy, Planning,
Legislation and International Affairs,
Food and Drug Administration, 301–
796–9115, Lisa.Granger@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of Tuesday, April 11,
2023 (88 FR 21688) in FR Doc. 2023–
248, the following corrections are made:
1. On page 21688, in the third
column, in the header of the document,
‘‘Docket No. FDA–2023–N–0378’’ is
corrected to read ‘‘Docket No. FDA–
2023–N–1338’’ and in the ADDRESSES
section, in the third line of the last
paragraph, ‘‘FDA–2023–N–0378’’ is
corrected to read ‘‘FDA–2023–N–1338.’’
2. On page 21689, in the first column,
in the second line of the ‘‘Instructions:’’
section, Docket No. FDA–2023–N–
0378’’ is corrected to read ‘‘Docket No.
FDA–2023–N–1338’’.
Dated: April 13, 2023.
Marquita Cullom,
Associate Director.
Dated: April 14, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–08247 Filed 4–18–23; 8:45 am]
[FR Doc. 2023–08279 Filed 4–18–23; 8:45 am]
BILLING CODE 4160–90–P
BILLING CODE 4164–01–P
VerDate Sep<11>2014
16:37 Apr 18, 2023
Jkt 259001
24191
[Docket No. FDA–2023–N–1338]
[Docket No. FDA–2019–N–3065]
Vaccines and Related Biological
Products Advisory Committee; Notice
of Meeting; Establishment of a Public
Docket; Request for Comments;
Correction
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments;
correction.
ACTION:
The Food and Drug
Administration is correcting a notice
entitled ‘‘Vaccines and Related
Biological Products Advisory
Committee; Notice of Meeting;
Establishment of a Public Docket;
Request for Comments’’ that appeared in
the Federal Register of April 11, 2023.
The document announced a
forthcoming public advisory committee
meeting of the Vaccines and Related
Biological Products Advisory
Committee. The document was
published with the incorrect docket
number. This document corrects that
error.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Tobacco Products;
Required Warnings for Cigarette
Packages and Advertisements
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
SUMMARY:
Submit written comments
(including recommendations) on the
collection of information by May 19,
2023.
DATES:
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be submitted to https://
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
Review—Open for Public Comments’’ or
by using the search function. The OMB
control number for this information
collection is 0910–0877. Also include
the FDA docket number found in
brackets in the heading of this
document.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Amber Sanford, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–8867, PRAStaff@
fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\19APN1.SGM
19APN1
]]>Agencies
[Federal Register Volume 88, Number 75 (Wednesday, April 19, 2023)]
[Notices]
[Pages 24190-24191]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08247]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment for the
Emergency Medical Error Reduction Group PSO
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to
list as a patient safety organization (PSO) an entity that attests that
it meets the statutory and regulatory requirements for listing. A PSO
can be ``delisted'' by the Secretary if it is found to no longer meet
the requirements of the Patient Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses
to voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ accepted a notification of proposed
voluntary relinquishment from the Emergency Medical Error Reduction
Group PSO, PSO number P0235, of its status as a PSO, and has delisted
the PSO accordingly.
DATES: The delisting was effective at 12:00 Midnight ET (2400) on March
29, 2023.
ADDRESSES: The directories for both listed and delisted PSOs are
ongoing and reviewed weekly by AHRQ. Both directories can be accessed
electronically at the following HHS website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866)
[[Page 24191]]
438-7231; TTY (local): (301) 427-1130; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the
related Patient Safety Rule, 42 CFR part 3, published in the Federal
Register on November 21, 2008 (73 FR 70732-70814), establish a
framework by which individuals and entities that meet the definition of
provider in the Patient Safety Rule may voluntarily report information
to PSOs listed by AHRQ, on a privileged and confidential basis, for the
aggregation and analysis of patient safety work product.
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of PSOs.
AHRQ has accepted a notification of proposed voluntary
relinquishment from the Emergency Medical Error Reduction Group PSO to
voluntarily relinquish its status as a PSO. Accordingly, the Emergency
Medical Error Reduction Group PSO, P0235, was delisted effective at
12:00 Midnight ET (2400) on March 29, 2023.
More information on PSOs can be obtained through AHRQ's PSO website
at https://www.pso.ahrq.gov.
Dated: April 13, 2023.
Marquita Cullom,
Associate Director.
[FR Doc. 2023-08247 Filed 4-18-23; 8:45 am]
BILLING CODE 4160-90-P
